CG
DNA icon

Cutler Group’s Ginkgo Bioworks DNA Stock Holding History

Cutler Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$8K Sell
193
-5
-3% -$259 ﹤0.01% 1366
2023
Q4 		$13K Sell
198
-95
-32% -$5.82K ﹤0.01% 2223
2023
Q3 		$21K Buy
293
+14
+5% +$1.12K ﹤0.01% 1986
2023
Q2 		$20K Sell
279
-94
-25% -$5.56K ﹤0.01% 1843
2023
Q1 		$19K Buy
373
+34
+10% +$2.15K ﹤0.01% 1946
2022
Q4 		$22K Buy
339
+146
+76% +$13.4K ﹤0.01% 2140
2022
Q3 		$24K Sell
193
-397
-67% -$47.3K ﹤0.01% 2465
2022
Q2 		$56K Buy
590
+61
+12% +$7.44K 0.01% 1863
2022
Q1 		$85K Sell
529
-123
-19% -$23.9K 0.01% 1814
2021
Q4 		$216K Buy
652
+148
+29% +$70.3K 0.01% 1255
2021
Q3 		$233K Buy
+504
New +$245K 0.02% 1252

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return